183 related articles for article (PubMed ID: 17198870)
21. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
[TBL] [Abstract][Full Text] [Related]
22. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
23. Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology.
Stergiou IE; Kambas K; Poulaki A; Giannouli S; Katsila T; Dimitrakopoulou A; Vidali V; Mouchtouris V; Kloukina I; Xingi E; Pagakis SN; Probert L; Patrinos GP; Ritis K; Tzioufas AG; Voulgarelis M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921064
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
Shih LY; Chiu WF; Lee CT
Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
[TBL] [Abstract][Full Text] [Related]
25. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.
Park CH; Kimler BF; Bodensteiner D; Lynch SR; Hassanein RS
Cancer Res; 1992 Aug; 52(16):4458-66. PubMed ID: 1643638
[TBL] [Abstract][Full Text] [Related]
26. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu
Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630
[TBL] [Abstract][Full Text] [Related]
27. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R.
Li B; Liu J; Qu S; Gale RP; Song Z; Xing R; Liu J; Ren Y; Xu Z; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Hu N; Cai W; Zhang P; Huang G; Xiao Z
Oncotarget; 2016 Oct; 7(42):68023-68032. PubMed ID: 27655727
[TBL] [Abstract][Full Text] [Related]
28. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
[TBL] [Abstract][Full Text] [Related]
29. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients.
Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT
Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000
[TBL] [Abstract][Full Text] [Related]
30. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Mayani H; Baines P; Bowen DT; Jacobs A
Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
Weimar IS; Voermans C; Bourhis JH; Miranda N; van den Berk PC; Nakamura T; de Gast GC; Gerritsen WR
Leukemia; 1998 Aug; 12(8):1195-203. PubMed ID: 9697873
[TBL] [Abstract][Full Text] [Related]
32. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.
Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M
Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740
[TBL] [Abstract][Full Text] [Related]
33. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2014 May; 86(3):207-15. PubMed ID: 24474614
[TBL] [Abstract][Full Text] [Related]
34. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions.
Span LF; Rutten E; Gemmink A; Boezeman JB; Raymakers RA; de Witte T
Leuk Res; 2007 Dec; 31(12):1659-67. PubMed ID: 17659774
[TBL] [Abstract][Full Text] [Related]
36. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.
Tohyama K; Ueda T; Yoshida Y; Nakamura T
Exp Hematol; 1994 Jul; 22(7):539-45. PubMed ID: 7516887
[TBL] [Abstract][Full Text] [Related]
37. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
38. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
Zhang Z; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
[TBL] [Abstract][Full Text] [Related]
39. [STAT5 phosphorylation in CD34(+)CD38(-)CD123(+) bone marrow cells of the patients with myelodysplastic syndrome].
Liu BN; Fu R; Wang HQ; Li LJ; Yue LZ; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Xing LM; Guan J; Wang J; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):480-3. PubMed ID: 22967386
[TBL] [Abstract][Full Text] [Related]
40. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
